Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men.

Ellsworth GB, Lensing SY, Ogilvie CB, Lee JY, Goldstone SE, Berry-Lawhorn JM, Jay N, Stier EA, Logan JS, Einstein MH, Saah A, Mitsuyasu RT, Aboulafia D, Palefsky JM, Wilkin TJ.

Papillomavirus Res. 2018 Dec;6:11-14. doi: 10.1016/j.pvr.2018.05.001. Epub 2018 May 26. No abstract available.

2.

An autograph letter of Dr. Rene Laennec.

Logan JS.

Anatol J Cardiol. 2016 Mar;16(3):230-2. doi: 10.14744/AnatolJCardiol.2016.. No abstract available.

3.

The treatment of arthritis of the wrist.

Logan JS, Warwick D.

Bone Joint J. 2015 Oct;97-B(10):1303-8. doi: 10.1302/0301-620X.97B10.35717. Review.

PMID:
26430002
4.

TriLink: Anatomic Double-Bundle Anterior Cruciate Ligament Reconstruction.

Yasen SK, Logan JS, Smith JO, Nancoo T, Risebury MJ, Wilson AJ.

Arthrosc Tech. 2013 Nov 28;3(1):e13-20. doi: 10.1016/j.eats.2013.08.004. eCollection 2014 Feb.

5.

Anatomic all-inside anterior cruciate ligament reconstruction using the translateral technique.

Wilson AJ, Yasen SK, Nancoo T, Stannard R, Smith JO, Logan JS.

Arthrosc Tech. 2013 Mar 24;2(2):e99-e104. doi: 10.1016/j.eats.2012.12.002. Print 2013 May.

6.

TransLateral ACL reconstruction: a technique for anatomic anterior cruciate ligament reconstruction.

Logan JS, Elliot RR, Wilson AJ.

Knee Surg Sports Traumatol Arthrosc. 2012 Jul;20(7):1289-92. doi: 10.1007/s00167-011-1745-0. Epub 2011 Nov 18.

PMID:
22095484
7.

A new technique for hamstring donor site blockade in anterior cruciate ligament reconstruction.

Logan JS, Elliot RR, Wilson AJ.

Ann R Coll Surg Engl. 2011 May;93(4):326. doi: 10.1308/003588411X570909i. No abstract available.

8.

Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.

McGregor CG, Carpentier A, Lila N, Logan JS, Byrne GW.

J Thorac Cardiovasc Surg. 2011 Jan;141(1):269-75. doi: 10.1016/j.jtcvs.2010.08.064.

9.

Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation.

Byrne GW, Stalboerger PG, Davila E, Heppelmann CJ, Gazi MH, McGregor HC, LaBreche PT, Davies WR, Rao VP, Oi K, Tazelaar HD, Logan JS, McGregor CG.

Xenotransplantation. 2008 Jul-Aug;15(4):268-76. doi: 10.1111/j.1399-3089.2008.00480.x.

10.

Thermoregulatory models of space shuttle and space station activities.

Pisacane VL, Kuznetz LH, Logan JS, Clark JB, Wissler EH.

Aviat Space Environ Med. 2007 Apr;78(4 Suppl):A48-55.

PMID:
17511299
11.

Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival.

Byrne GW, Davies WR, Oi K, Rao VP, Teotia SS, Ricci D, Tazelaar HD, Walker RC, Logan JS, McGregor CG.

Transplantation. 2006 Dec 27;82(12):1787-91.

PMID:
17198277
12.

Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction.

Gaca JG, Appel JZ 3rd, Lukes JG, Gonzalez-Stawinski GV, Lesher A, Palestrant D, Logan JS, Love SD, Holzknecht ZE, Platt JL, Parker W, Davis RD.

Transplantation. 2006 Jun 27;81(12):1686-94.

PMID:
16794535
13.

T-cell responses during pig-to-primate xenotransplantation.

Davila E, Byrne GW, LaBreche PT, McGregor HC, Schwab AK, Davies WR, Rao VP, Oi K, Tazelaar HD, Logan JS, McGregor CG.

Xenotransplantation. 2006 Jan;13(1):31-40.

PMID:
16497210
14.

Epidemic jaundice: Harvard's 5th General Hospital at Musgrave Park in World War II.

Logan JS, Logan JI.

Ulster Med J. 2006 Jan;75(1):91; author reply 91. No abstract available.

15.

Cardiac xenotransplantation: recent preclinical progress with 3-month median survival.

McGregor CG, Davies WR, Oi K, Teotia SS, Schirmer JM, Risdahl JM, Tazelaar HD, Kremers WK, Walker RC, Byrne GW, Logan JS.

J Thorac Cardiovasc Surg. 2005 Sep;130(3):844-51.

16.

Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function.

Byrne GW, Schirmer JM, Fass DN, Teotia SS, Kremers WK, Xu H, Naziruddin B, Tazelaar HD, Logan JS, McGregor CG.

Am J Transplant. 2005 May;5(5):1011-20.

17.

Prevention, detection, and management of early bacterial and fungal infections in a preclinical cardiac xenotransplantation model that achieves prolonged survival.

Teotia SS, Walker RC, Schirmer JM, Tazelaar HD, Michaels MG, Risdahl JM, Byrne GW, Logan JS, McGregor CG.

Xenotransplantation. 2005 Mar;12(2):127-33.

PMID:
15693843
18.

Cardiac xenotransplantation: progress toward the clinic.

McGregor CG, Teotia SS, Byrne GW, Michaels MG, Risdahl JM, Schirmer JM, Tazelaar HD, Walker RC, Logan JS.

Transplantation. 2004 Dec 15;78(11):1569-75.

PMID:
15591943
19.

Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival.

Schirmer JM, Fass DN, Byrne GW, Tazelaar HD, Logan JS, McGregor CG.

Xenotransplantation. 2004 Sep;11(5):436-43.

PMID:
15303980
20.

Skin graft survival in genetically identical cloned pigs.

Martin MJ, Yin D, Adams C, Houtz J, Shen J, Chong AS, Sharma A, Byrne GW, Wiseman BS, Logan JS.

Cloning Stem Cells. 2003;5(2):117-21.

PMID:
12930623
21.

Serologic analysis of anti-porcine endogenous retroviruses immune responses in humans after ex vivo transgenic pig liver perfusion.

Xu H, Sharma A, Okabe J, Cui C, Huang L, Wei YY, Wan H, Lei Y, Logan JS, Levy MF, Byrne GW.

ASAIO J. 2003 Jul-Aug;49(4):407-16.

PMID:
12918582
22.

Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen.

Sharma A, Naziruddin B, Cui C, Martin MJ, Xu H, Wan H, Lei Y, Harrison C, Yin J, Okabe J, Mathews C, Stark A, Adams CS, Houtz J, Wiseman BS, Byrne GW, Logan JS.

Transplantation. 2003 Feb 27;75(4):430-6.

PMID:
12605105
23.

The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection.

Xu H, Yin D, Naziruddin B, Chen L, Stark A, Wei Y, Lei Y, Shen J, Logan JS, Byrne GW, Chong AS.

J Immunol. 2003 Feb 1;170(3):1531-9.

24.

Immunoaffinity removal of xenoreactive antibodies using modified dialysis or microfiltration membranes.

Karoor S, Molina J, Buchmann CR, Colton C, Logan JS, Henderson LW.

Biotechnol Bioeng. 2003 Jan 20;81(2):134-48.

PMID:
12451550
25.

CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice.

Yin D, Ma L, Shen J, Byrne GW, Logan JS, Chong AS.

Am J Transplant. 2002 Jan;2(1):41-7.

26.

Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate.

Diamond LE, Byrne GW, Schwarz A, Davis TA, Adams DH, Logan JS.

Transplantation. 2002 Jun 15;73(11):1780-7.

PMID:
12085001
27.

Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation.

Gonzalez-Stawinski GV, Daggett CW, Lau CL, Karoor S, Love SD, Logan JS, Gaca JG, Parker W, Davis RD Jr.

J Am Coll Surg. 2002 Jun;194(6):765-73.

PMID:
12081067
28.

Development and characterization of anti-Gal B cell receptor transgenic Gal-/- mice.

Xu H, Sharma A, Lei Y, Okabe J, Wan H, Chong AS, Logan JS, Byrne GW.

Transplantation. 2002 May 27;73(10):1549-57.

PMID:
12042639
29.

Evaluation of different alpha-Galactosyl glycoconjugates for use in xenotransplantation.

Byrne GW, Schwarz A, Fesi JR, Birch P, Nepomich A, Bakaj I, Velardo MA, Jiang C, Manzi A, Dintzis H, Diamond LE, Logan JS.

Bioconjug Chem. 2002 May-Jun;13(3):571-81.

PMID:
12009948
30.

Endothelial function in pigs transgenic for human complement regulating factor.

Warnecke G, Severson SR, Ugurlu MM, Taner CB, Logan JS, Diamond LE, Miller VM, McGregor CG.

Transplantation. 2002 Apr 15;73(7):1060-7.

PMID:
11965032
31.

The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice.

Xu H, Sharma A, Chen L, Harrison C, Wei Y, Chong AS, Logan JS, Byrne GW.

Transplantation. 2001 Dec 15;72(11):1817-25. Erratum in: Transplantation 2002 Apr 27;73(8):1369. Shama A [corrected to Sharma A].

PMID:
11740394
32.

The effect of anti-alphaGal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival.

Dean PG, Cohen AJ, Dalla Valle H, Grande JP, Diamond LE, Byrne GW, Logan JS, McGregor CG, Stegall MD.

Transplant Proc. 2001 Feb-Mar;33(1-2):721-2. No abstract available.

PMID:
11267038
33.

A strategic vision for telemedicine and medical informatics in space flight.

Williams DR, Bashshur RL, Pool SL, Doarn CR, Merrell RC, Logan JS.

Telemed J E Health. 2000 Winter;6(4):441-8.

34.

A human CD46 transgenic pig model system for the study of discordant xenotransplantation.

Diamond LE, Quinn CM, Martin MJ, Lawson J, Platt JL, Logan JS.

Transplantation. 2001 Jan 15;71(1):132-42.

PMID:
11211178
35.

The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.

Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, Lau CL, Parker W, Davis RD, Byrne GW, Diamond LE, Logan JS, Platt JL.

Transplantation. 2000 Dec 27;70(12):1667-74.

PMID:
11152095
36.

Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.

Chong AS, Ma L, Yin D, Shen J, Blinder L, XiuLong X, Williams JW, Byrne G, Diamond LE, Logan JS.

Xenotransplantation. 2000 Nov;7(4):275-83.

PMID:
11081762
37.
38.

Prospects for xenotransplantation.

Logan JS.

Curr Opin Immunol. 2000 Oct;12(5):563-8. Review.

PMID:
11007360
39.

The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants.

Lau CL, Daggett WC, Yeatman MF, Chai P, Lin SS, Lodge AJ, Chen EP, Diamond LE, Byrne GW, Logan JS, Parker W, Platt JL, Davis RD.

J Thorac Cardiovasc Surg. 2000 Jul;120(1):29-38.

40.

CD46 transgene expression in pig peripheral blood mononuclear cells does not alter their susceptibility to measles virus or their capacity to downregulate endogenous and transgenic CD46.

Schneider-Schaulies J, Martin MJ, Logan JS, Firsching R, ter Meulen V, Diamond LE.

J Gen Virol. 2000 Jun;81(Pt 6):1431-8.

PMID:
10811926
41.

Potential use of genetically modified pigs as organ donors for transplantation into humans.

Logan JS, Sharma A.

Clin Exp Pharmacol Physiol. 1999 Dec;26(12):1020-5. Review.

PMID:
10626075
42.

Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates.

Chen RH, Naficy S, Logan JS, Diamond LE, Adams DH.

Xenotransplantation. 1999 Aug;6(3):194-200.

PMID:
10503786
43.

Human complement regulatory proteins protect swine lungs from xenogeneic injury.

Yeatman M, Daggett CW, Lau CL, Byrne GW, Logan JS, Platt JL, Davis RD.

Ann Thorac Surg. 1999 Mar;67(3):769-75.

PMID:
10215226
44.

High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron 1.

Tone M, Diamond LE, Walsh LA, Tone Y, Thompson SA, Shanahan EM, Logan JS, Waldmann H.

J Biol Chem. 1999 Jan 8;274(2):710-6.

45.

Role of CD46 in measles virus infection in CD46 transgenic mice.

Blixenkrone-Møller M, Bernard A, Bencsik A, Sixt N, Diamond LE, Logan JS, Wild TF.

Virology. 1998 Sep 30;249(2):238-48.

46.

Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models.

Yeatman M, Daggett CW, Parker W, Byrne GW, Logan JS, Platt JL, Davis RD.

Transplantation. 1998 Apr 27;65(8):1084-93.

PMID:
9583870
47.

The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.

Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, Daniels LJ, Daggett CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS, Platt JL.

J Clin Invest. 1998 Apr 15;101(8):1745-56.

48.

Glycosyl phosphatidylinositol anchor.

Kooyman DL, Byrne GW, Logan JS.

Exp Nephrol. 1998 Mar-Apr;6(2):148-51. Review.

PMID:
9567221
49.

Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation.

McCurry KR, Parker W, Cotterell AH, Weidner BC, Lin SS, Daniels LJ, Holzknecht ZE, Byrne GW, Diamond LE, Logan JS, Platt JL.

Hum Immunol. 1997 Dec;58(2):91-105.

PMID:
9475338
50.

The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants.

Lin SS, Kooyman DL, Daniels LJ, Daggett CW, Parker W, Lawson JH, Hoopes CW, Gullotto C, Li L, Birch P, Davis RD, Diamond LE, Logan JS, Platt JL.

Transpl Immunol. 1997 Sep;5(3):212-8.

PMID:
9402688

Supplemental Content

Loading ...
Support Center